| Financial Year |
March 31 2023 |
| Monetary Funds |
656,516,804.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
137,822,864.15 |
| Accounts Receivable |
559,013,467.56 |
| Advances to Suppliers |
341,641,733.91 |
| Other Receivables |
64,745,512.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
639,319,118.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
11,408,890.88 |
| Other Current Assets |
47,998,691.81 |
| Total Current Assets |
2,763,148,854.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,114,233.07 |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,860,247.40 |
| Fixed Assetes |
1,888,697,579.98 |
| Under-construction Projects |
281,734,040.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
1,692,473,262.27 |
| Intangible Assets |
51,269,547.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
178,420,352.54 |
| Deferred Income Tax Assets |
2,810,893.19 |
| Other Non-Current Assets |
300,858,814.75 |
| Sub-Total of Non-Current Assets |
4,564,245,392.41 |
| Total Assets |
7,327,394,246.54 |
| Short-Term Loans |
883,168,451.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
126,150,000.00 |
| Accounts Payable |
882,306,529.73 |
| Accounts Received In Advance |
2,943,858.88 |
| Employee Compensation Payable |
70,124,557.38 |
| Taxes Payable |
274,304,228.48 |
| Interest Payable |
-- |
| Dividend Payable |
19,590,537.50 |
| Other payables |
183,458,378.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
488,446,985.86 |
| Other Current Liabilities |
96,448,651.12 |
| Sub-Total of Current Liabilities |
3,142,367,831.51 |
| Long-term Loans |
937,353,576.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
596,234,423.54 |
| Special Payable |
-- |
| Estimatied Liabilities |
78,208,499.76 |
| Deferred Income Tax Liabilities |
7,094,305.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,636,675,252.35 |
| Total Liabilities |
4,779,043,083.86 |
| Paid-In Capital(Or Share Stock) |
400,000,100.00 |
| Capital Surplus |
1,045,091,904.06 |
| Surplus Reserve |
133,975,964.75 |
| LESS:Treasury Stock |
119,989,753.38 |
| Undistributed Profits |
1,055,184,573.17 |
| Minority Stockholder's Interest |
-2,340,429.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,550,691,591.95 |
| Owner's Equity（Stockholder's Equity） |
2,548,351,162.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,327,394,246.54 |
